-
Research | Education
Diabetes Publishes Review by Dr. Remi Creusot and his lab.
Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?
The latest issue of the journal Diabetes has published a review by Dr. Remi Creusot and his lab colleagues.
-
Research | Education
Principal Investigator Remi Creusot to Present Three Posters at IDS Congress 2018
Dr. Remi Creusot has had three abstracts chosen for presentation at this year's IDS Congress in London, England.
-
Students | Research | Profile | Education
Dr. Megan Sykes' iBiology Talk
The Immune Response to Allo-and Xenotransplantation
CCTI Director Dr. Megan Sykes presented The Immune Response to Allo- and Xenotransplantation on iBiology.org
-
Profile
Dr. Adam Griesemer Appointed NYP Surgical Director of Pediatric Liver Transplant Program
Adam D. Griesemer, MD
Assistant Professor of Surgery at CUMC
Director, Large Animal Xenotransplantation Laboratory, Columbia Center for Translational Immunology
-
Profile | Academics
Dr. Megan Sykes Receives 2018 Medawar Prize
The CCTI is incredibly proud to announce Director Dr. Megan Sykes has been awarded the 2018 Medawar Prize.
-
Research | Academics
The CCTI at ATC 2018
June 2-6 Seattle, Washington
Once again, the CCTI is front-and center at the annual American Transplant Congress (ATC).
-
Research | Global Health
Dr. Christian Schuetz to Chair ADA Session
Dr. Christian Schuetz to Chair ADA Session in June.
-
Research | Global Health
Dr. Megan Sykes to Give a Keynote Lecture at FOCIS 2018
CCTI Director Dr. Megan Sykes will present "Taming a Colossal Giant: The Human Allograft Response" at FOCIS 2018
-
Research
CCTI Presenters at 2018 FOCIS
The CCTI is proud to be sending several presenters to this year's FOCIS meeting!
-
Research | Global Health
The CCTI at the 2018 Transplantation Society's 28th International Congress
Once again the CCTI will be well represented at The Transplantation Society's annual Congress, this year being held in Madrid, Spain, June 30- July 5th. Following is the most current agenda for...
